行情

ONVO

ONVO

Organovo控股
NASDAQ

实时行情|Nasdaq Last Sale

0.3294
+0.0395
+13.63%
盘后: 0.3000 -0.0294 -8.93% 17:58 04/08 EDT
开盘
0.2801
昨收
0.2899
最高
0.3329
最低
0.2621
成交量
107.81万
成交额
--
52周最高
1.050
52周最低
0.1933
市值
4,298.59万
市盈率(TTM)
-1.8059
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ONVO价格均价为3.000,最高价位3.000,最低价为3.000。

EPS

ONVO 新闻

更多
  • The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
  • Benzinga · 9小时前
  • The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
  • Benzinga · 10小时前
  • Edited Transcript of ONVO earnings conference call or presentation 9-Nov-17 10:00pm GMT
  • Thomson Reuters StreetEvents · 14小时前
  • Organovo stockholders nix Tarveda merger; shares up 2% after hours
  • seekingalpha · 20小时前

所属板块

生物技术和医学研究
+3.08%
制药与医学研究
+2.83%

热门股票

代码
价格
涨跌幅

ONVO 简况

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.
展开

微牛提供Organovo Holdings Inc(NASDAQ-ONVO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ONVO股票新闻,以帮助您做出投资决策。